Germany Blood Glucose Monitoring Market Insight
Published: 18 May 2026 | Report Format: Electronic (PDF)
The Germany Blood Glucose Monitoring Market size is growing at a 7.5% CAGR, driven by high diabetes incidence rate, robust healthcare insurance schemes, and growing demand for real-time CGM systems
Germany Blood Glucose Monitoring Market Insights and Forecasts to 2035
- The Germany Blood Glucose Monitoring Market Size Was Estimated at USD 1,152.5 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 7.5% from 2025 to 2035
- The Germany Blood Glucose Monitoring Market Size is Expected to Reach USD 2,374.8 Million by 2035
Notable Insights for the Germany Blood Glucose Monitoring Market
- By product type, continuous glucose monitoring dominates the market, accounting for approximately 58-60% share in 2025. They are preferred because they show glucose trends immediately, minimize testing on fingers, and are covered by many German health insurers.
- By end user, home care setting dominates the market, accounting for approximately 70-74% share in 2025. Homecare is predominant since most people manage diabetes independently and utilize portable glucometers linked to their phones.
- As per the data available from the International Diabetes Federation, Germany accounts for around 8.9 million people suffering from diabetes, placing it among Europe's major markets for diabetic care.
Download the eBook (ToC)
- Healthcare spending on diabetes in Germany exceeds €35 billion (USD 40.77 billion) every year, providing strong reimbursement coverage for glucose meters.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Germany blood glucose monitoring market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Germany Blood Glucose Monitoring Market
- Abbott Laboratories Deutschland GmbH
- Roche Diabetes Care Deutschland GmbH
- DexCom Deutschland GmbH
- Medtronic GmbH
- Ascensia Diabetes Care Deutschland GmbH
- Ypsomed GmbH
- Senseonics Holdings, Inc.
- Sinocare Europe GmbH
- Menarini Diagnostics Deutschland
- Braun Melsungen AG
Recent Developments:
- In July 2025, Abbott Diabetes Care signed deals with German health insurance companies, extending its agreement to provide more Freestyle Libre CGM systems to more people suffering from Type 2 diabetes.
Market Segmentation:
Germany Blood Glucose Monitoring Market, By Product Type
- Self-Monitoring Blood Glucose (SMBG) Meters
- Continuous Glucose Monitoring (CGM) Systems
- Test Strips and Lancets
Germany Blood Glucose Monitoring Market, By End User
- Home Care Settings
- Hospitals & Clinics
- Diagnostic Laboratories
Germany Blood Glucose Monitoring Market, By Distribution Channel
- Retail Pharmacies
- Online Channels
- Direct-to-Patient Supply
Expert Views:
There will be steady growth in the German market for blood glucose monitoring owing to reimbursement and adoption of CGMs within the type 1 and type 2 diabetes market segment. With the presence of companies like Abbott, Roche, Dexcom, and Medtronic and a relatively large number of insulin-dependent people in Germany, the market is considered one of the best in Europe.